Welspun Corp bets on US, Saudi growth as overall order book rises to ₹45,000 crore

Mumbai-based manufacturer of large-diameter pipes Welspun Corp expects strong growth over the next few years, supported by a robust order book, expanding US operations, and rising opportunities in Saudi Arabia. Vipul Mathur, MD & CEO, Welspun Corp, said the company’s order book has extended visibility up to 2029-30. The company recently secured a large high-frequency…

Read More

Access Denied

Access Denied You don’t have permission to access “http://www.etnownews.com/markets/bank-nifty-today-nifty-bank-falls-nearly-2-yes-bank-union-bank-among-top-losers-check-key-reasons-article-156239038” on this server. Reference #18.26fdd417.1790576353.fb595c0 https://errors.edgesuite.net/18.26fdd417.1790576353.fb595c0 Source link

Read More

Access Denied

Access Denied You don’t have permission to access “http://www.etnownews.com/markets/stock-market-crash-today-3-reasons-sensex-nifty-fell-on-sep-28-crude-oil-us-yields-fii-outflow-article-156238870” on this server. Reference #18.8d533617.1790574125.16934ded https://errors.edgesuite.net/18.8d533617.1790574125.16934ded Source link

Read More

Access Denied

Access Denied You don’t have permission to access “http://www.etnownews.com/markets/srit-india-ipo-day-1-price-band-gmp-listing-date-lot-size-subscription-details-article-156238546” on this server. Reference #18.3cfdd417.1790570903.11d933d1 https://errors.edgesuite.net/18.3cfdd417.1790570903.11d933d1 Source link

Read More

Access Denied

Access Denied You don’t have permission to access “http://www.etnownews.com/markets/shah-investors-home-ipo-day-1-gmp-at-rs-9-brokerage-says-avoid-check-key-positives-concerns-article-156238602” on this server. Reference #18.5fdd417.1790569811.5fe509d https://errors.edgesuite.net/18.5fdd417.1790569811.5fe509d Source link

Read More

Sun Pharma inks global licensing deal with LIB Therapeutics for bad cholesterol treatment drug

Shares of Sun Pharmaceutical Industries Ltd. are in focus on Monday, September 28, after it announced licensing, commericalisation and manufacturing agreement with LIB Tehrapeutics for a bad cholesterol treatment drug known as lerodalcibep. Lerodalcibep is approved in the EU under the brand name Lyrokaul for the treatment of adult patients with hypercholestrolaemia and mixed dyslipidaemia,…

Read More